The SURPASS-CVOT trial, where dulaglutide at the dose of 1.5 mg/week or at the highest tolerated dose, is the comparator, has a distinctive design from the other trials: the primary endpoint is the time to the first manifestation of any major adverse CV event (MACE), defined as myocardial infarction, stroke or CV death
To understand tirzepatide-specific timing, how fast tirzepatide works covers the pharmacokinetic details, and how long it takes for tirzepatide to work addresses onset expectations
But when you add Vitamin B5 (Pantothenic Acid) to the mix, the real magic happens
If you have constipation Choose: Oatmeal + protein drink Or: Protein box with fruit Why: Cleveland Clinic highlights fiber as important because constipation can happen on GLP-1s
What concentrations are used in cell culture
Can I switch between injectable and oral GLP-1s